Target intelligence / Profile preview

Major histocompatibility complex protein (MHC protein) (MHC)

Target
MHC
Molecular classification
Receptor, Transmembrane protein, Other (antigen-presenting protein)
01

Overview

Major histocompatibility complex proteins (MHC proteins) are transmembrane glycoproteins expressed on the surface of cells that present peptide antigens derived from intracellular or extracellular proteins, and are recognized by T cell receptors, thereby initiating and regulating immune responses. Class I MHC proteins present intracellular peptides to CD8+ cytotoxic T cells, while Class II MHC proteins present extracellular peptides to CD4+ helper T cells. MHC proteins are essential for self/non-self recognition and are involved in responses to infectious disease, cancer, autoimmunity, and transplant rejection. The presenting peptide, termed antigen, is typically 8–11 amino acids long for Class I and longer for Class II, and both protein and bound peptide form the ligand recognized by T cells.

Other names
Major histocompatibility complex moleculeMHCHLA (human leukocyte antigen, in humans)MHC class IMHC class II
02

Mechanism of action

Competitive blockade of antigen presentation; Modulation of peptide loading and presentation; Alteration of T cell activation/immune modulation

03

Biological functions

Antigen presentationImmune response activation (T cell activation)Self/non-self discrimination
04

Disease associations

Cancer (immune evasion via altered antigen presentation)Infection (viral immune escape mechanisms)Autoimmune disease (e.g., by presenting self-peptides)Transplant rejection (HLA mismatch)
05

Safety considerations

Autoimmunity (self-peptide presentation)Graft-versus-host disease (transplant mismatch)Immunotherapy-associated toxicity (overactivation of immune responses)
06

Interacting drugs

Immunosuppressants (targeting antigen presentation indirectly, e.g., cyclosporine, tacrolimus)

2 more in the full profile.

07

Biomarkers

HLA typing for transplant matchingSpecific peptide-MHC complexes for assessing immune response or vaccine efficacyMHC protein expression (IFNγ-induced upregulation)

Beyond the preview

Go deeper on Major histocompatibility complex protein (MHC protein) (MHC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex protein (MHC protein) (MHC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call